Jump to navigation Jump to search

WikiDoc Resources for Lipoatrophy


Most recent articles on Lipoatrophy

Most cited articles on Lipoatrophy

Review articles on Lipoatrophy

Articles on Lipoatrophy in N Eng J Med, Lancet, BMJ


Powerpoint slides on Lipoatrophy

Images of Lipoatrophy

Photos of Lipoatrophy

Podcasts & MP3s on Lipoatrophy

Videos on Lipoatrophy

Evidence Based Medicine

Cochrane Collaboration on Lipoatrophy

Bandolier on Lipoatrophy

TRIP on Lipoatrophy

Clinical Trials

Ongoing Trials on Lipoatrophy at Clinical

Trial results on Lipoatrophy

Clinical Trials on Lipoatrophy at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Lipoatrophy

NICE Guidance on Lipoatrophy


FDA on Lipoatrophy

CDC on Lipoatrophy


Books on Lipoatrophy


Lipoatrophy in the news

Be alerted to news on Lipoatrophy

News trends on Lipoatrophy


Blogs on Lipoatrophy


Definitions of Lipoatrophy

Patient Resources / Community

Patient resources on Lipoatrophy

Discussion groups on Lipoatrophy

Patient Handouts on Lipoatrophy

Directions to Hospitals Treating Lipoatrophy

Risk calculators and risk factors for Lipoatrophy

Healthcare Provider Resources

Symptoms of Lipoatrophy

Causes & Risk Factors for Lipoatrophy

Diagnostic studies for Lipoatrophy

Treatment of Lipoatrophy

Continuing Medical Education (CME)

CME Programs on Lipoatrophy


Lipoatrophy en Espanol

Lipoatrophy en Francais


Lipoatrophy in the Marketplace

Patents on Lipoatrophy

Experimental / Informatics

List of terms related to Lipoatrophy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Kiran Singh, M.D. [2]


Lipoatrophy is the term describing the localized loss of fat tissue. This may occur as a result of subcutanous injections of insulin in the treatment of diabetes, or from subcutanous injections of Copaxone used for the treatment of multiple sclerosis. In the latter case, an injection may produce a small dent at the injection site.[1] Lipoatrophy is also an adverse drug reaction that is associated with some antiretroviral drugs.[2]


Physical Examination




  1. Radermecker RP, Piérard GE, Scheen AJ (2007). "Lipodystrophy reactions to insulin: effects of continuous insulin infusion and new insulin analogs". American journal of clinical dermatology. 8 (1): 21–8. PMID 17298103.
  2. Barbaro G (2007). "Visceral fat as target of highly active antiretroviral therapy-associated metabolic syndrome". Curr. Pharm. Des. 13 (21): 2208–13. PMID 17627554.
  3. 3.0 3.1 3.2 3.3 "Dermatology Atlas".

Template:WikiDoc Sources